> News Center > Press Releases
Press Releases

 
Display # 
 Date Item Title  
6 Nov 2006 November 2006, recent research supports Apoxis’ selection of cancer target  
2 Feb 2006 Apoxis receives FDA Orphan Medicinal Product designation for APO200 for the treatment of XLHED  
15 Dec 2005 Apoxis Acquires Worldwide Rights for Novel Anti-Cancer Compound from Astellas Pharma  
22 Jun 2005 Apoxis announces agreement for recombinant protein production with the Swiss-based company Berna Bio  
12 Apr 2005 Apoxis S.A. selected by Red Herring as one of the 100 top private companies in Europe  
25 Jan 2005 Apoxis completes a second round of financing of 15 million euros  
16 Mar 2004 Apoxis SA announces first round of financing  
16 Mar 2004 Apoxis awarded the “Oscar” of Swiss Technology  

<< Start < Previous        Next > End >>
Results 1 - 8 of 8
 
  News (2 items)
  Press Releases